We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,212
Reduced
6,339
Closed
1,910

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Financials 2.35%
3 Healthcare 2.22%
4 Consumer Discretionary 2.21%
5 Communication Services 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMK
13551
PUT
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$10K ﹤0.01%
247
-484
-66% -$30.2K
MTCR
13552
DELISTED
Metacrine, Inc. Common Stock
MTCR
$10K ﹤0.01%
14,672
-17,757
-55% -$31.7K
ITRM
13553
DELISTED
Iterum Therapeutics
ITRM
$9K ﹤0.01%
+1,493
New +$11.5K
BEST
13554
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$9K ﹤0.01%
503
-2,517
-83% -$68.1K
OCAXW
13555
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$9K ﹤0.01%
19,110
-6,897
-27% -$3.74K
ACKIW
13556
DELISTED
Ackrell SPAC Partners I Co Warrants
ACKIW
$9K ﹤0.01%
17,115
-870
-5% -$483
NBRV
13557
PUT
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$9K ﹤0.01%
592
+60
+11% +$1.42K
ITP icon
13558
PUT
IT Tech Packaging
ITP
$2.91M
$8K ﹤0.01%
3,470
+1,310
+61% +$4.41K
TWLVW
13559
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$8K ﹤0.01%
15,820
-13,611
-46% -$8.55K
AGILW
13560
DELISTED
AgileThought Inc Warrant
AGILW
$8K ﹤0.01%
12,744
-90
-0.7% -$81
MTCR
13561
PUT
DELISTED
Metacrine, Inc. Common Stock
MTCR
$8K ﹤0.01%
+11,300
New +$20.2K
RMTI icon
13562
CALL
Rockwell Medical
RMTI
$29.2M
$7K ﹤0.01%
+148
New +$7.93K
TLPH icon
13563
PUT
Talphera
TLPH
$63.8M
$7K ﹤0.01%
+665
New +$10.1K
CSCI
13564
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$7K ﹤0.01%
197
-32
-14% -$1.69K
GHSI
13565
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$7K ﹤0.01%
211
-128
-38% -$6.87K
ARYD
13566
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$7K ﹤0.01%
694
-718
-51% -$7.15K
PRSTW
13567
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$6K ﹤0.01%
12,517
-805,504
-98% -$315K
EMWP
13568
PUT
DELISTED
Eros Media World PLC
EMWP
$6K ﹤0.01%
1,155
-4,640
-80% -$53K
RGLS
13569
CALL
DELISTED
Regulus Therapeutics
RGLS
$5K ﹤0.01%
1,550
-3,350
-68% -$14.9K
AUMN
13570
DELISTED
Golden Minerals Company
AUMN
$5K ﹤0.01%
594
-10,001
-94% -$106K
TRX icon
13571
TRX Gold Corp
TRX
$367M
$4K ﹤0.01%
+10,793
New +$4.68K
BREZR
13572
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$4K ﹤0.01%
19,125
-575
-3% -$132
GPL
13573
DELISTED
Great Panther Mining Limited
GPL
$4K ﹤0.01%
1,869
-560
-23% -$1.91K
HYMCZ
13574
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$3K ﹤0.01%
16,552
-1,036
-6% -$273
VTAQR
13575
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$3K ﹤0.01%
12,517
-550,219
-98% -$132K

Similar funds

Ken Griffin's Q4 2021 Portfolio in Review

As of Q4 2021, Ken Griffin held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin withdrew a net $30B in Q4 2021, closing 1,910 positions and reducing 6,339 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Ken Griffin's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Ken Griffin added most to Amazon in Q4 2021, an estimated $802M increase.
  • Ken Griffin's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Ken Griffin fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Ken Griffin's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Ken Griffin opened 1,894 new positions and closed 1,910 in Q4 2021.
  • Ken Griffin's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.